Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Topic collections
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Topic collections
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
wet age-related macular degeneration
Email alerts
wet age-related macular degeneration
Effectiveness and safety of intravitreal aflibercept in patients with wet age-related macular degeneration treated in routine clinical practices across France: 12-month outcomes of the RAINBOW study
Michel
Weber
,
Laurent
Velasque
,
Florence
Coscas
,
Céline
Faure
,
Isabelle
Aubry
,
Salomon Y
Cohen
BMJ Open Ophthalmology
Apr 2019,
4
(1)
e000109;
DOI:
10.1136/bmjophth-2017-000109
Special collections
BMJ Open Ophthalmology
Biomaterials
(2)
Cornea and Ocular Surface
(37)
Genetics
(8)
Glaucoma
(37)
Global Ophthalmology
(27)
Lens
(7)
Neuro-Ophthalmology
(11)
Ocular Oncology
(5)
Orbit and Oculoplastics
(6)
Paediatric Ophthalmology
(33)
Retina
(62)
Uveitis
(7)
Vision Science
(13)
COVID-19
(27)
Editor's choice
Guidelines, Recommendations and Consensus Statements
Press releases
